PMC:7402624 / 17044-17324 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T118","span":{"begin":28,"end":31},"obj":"Body_part"},{"id":"T119","span":{"begin":91,"end":96},"obj":"Body_part"},{"id":"T120","span":{"begin":135,"end":138},"obj":"Body_part"}],"attributes":[{"id":"A118","pred":"fma_id","subj":"T118","obj":"http://purl.org/sig/ont/fma/fma67847"},{"id":"A119","pred":"fma_id","subj":"T119","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A120","pred":"fma_id","subj":"T120","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"A major region of this tSNE map present in COVID-19 patients, but not HD or RD, were CD8 T cells that enriched for expression of CD38, HLA-DR, KI67, CD39, and PD1 (Fig. 2G), highlighting the co-expression of these activation markers with other features including CD95 (i.e., FAS)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"574","span":{"begin":85,"end":88},"obj":"Gene"},{"id":"575","span":{"begin":129,"end":133},"obj":"Gene"},{"id":"576","span":{"begin":149,"end":153},"obj":"Gene"},{"id":"577","span":{"begin":159,"end":162},"obj":"Gene"},{"id":"578","span":{"begin":263,"end":267},"obj":"Gene"},{"id":"596","span":{"begin":52,"end":60},"obj":"Species"},{"id":"604","span":{"begin":43,"end":51},"obj":"Disease"},{"id":"605","span":{"begin":70,"end":72},"obj":"Disease"}],"attributes":[{"id":"A574","pred":"tao:has_database_id","subj":"574","obj":"Gene:925"},{"id":"A575","pred":"tao:has_database_id","subj":"575","obj":"Gene:952"},{"id":"A576","pred":"tao:has_database_id","subj":"576","obj":"Gene:953"},{"id":"A577","pred":"tao:has_database_id","subj":"577","obj":"Gene:6622"},{"id":"A578","pred":"tao:has_database_id","subj":"578","obj":"Gene:355"},{"id":"A596","pred":"tao:has_database_id","subj":"596","obj":"Tax:9606"},{"id":"A604","pred":"tao:has_database_id","subj":"604","obj":"MESH:C000657245"},{"id":"A605","pred":"tao:has_database_id","subj":"605","obj":"MESH:D006816"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A major region of this tSNE map present in COVID-19 patients, but not HD or RD, were CD8 T cells that enriched for expression of CD38, HLA-DR, KI67, CD39, and PD1 (Fig. 2G), highlighting the co-expression of these activation markers with other features including CD95 (i.e., FAS)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T128","span":{"begin":43,"end":51},"obj":"Disease"},{"id":"T129","span":{"begin":70,"end":72},"obj":"Disease"},{"id":"T130","span":{"begin":76,"end":78},"obj":"Disease"},{"id":"T131","span":{"begin":275,"end":278},"obj":"Disease"}],"attributes":[{"id":"A128","pred":"mondo_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A129","pred":"mondo_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/MONDO_0007739"},{"id":"A130","pred":"mondo_id","subj":"T130","obj":"http://purl.obolibrary.org/obo/MONDO_0009973"},{"id":"A131","pred":"mondo_id","subj":"T131","obj":"http://purl.obolibrary.org/obo/MONDO_0016011"}],"text":"A major region of this tSNE map present in COVID-19 patients, but not HD or RD, were CD8 T cells that enriched for expression of CD38, HLA-DR, KI67, CD39, and PD1 (Fig. 2G), highlighting the co-expression of these activation markers with other features including CD95 (i.e., FAS)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T277","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T278","span":{"begin":76,"end":78},"obj":"http://purl.obolibrary.org/obo/CLO_0008770"},{"id":"T279","span":{"begin":85,"end":88},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T280","span":{"begin":89,"end":96},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T281","span":{"begin":129,"end":133},"obj":"http://purl.obolibrary.org/obo/PR_000001408"},{"id":"T282","span":{"begin":214,"end":224},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"A major region of this tSNE map present in COVID-19 patients, but not HD or RD, were CD8 T cells that enriched for expression of CD38, HLA-DR, KI67, CD39, and PD1 (Fig. 2G), highlighting the co-expression of these activation markers with other features including CD95 (i.e., FAS)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T84","span":{"begin":70,"end":72},"obj":"Chemical"},{"id":"T85","span":{"begin":76,"end":78},"obj":"Chemical"},{"id":"T86","span":{"begin":139,"end":141},"obj":"Chemical"},{"id":"T87","span":{"begin":159,"end":162},"obj":"Chemical"},{"id":"T88","span":{"begin":275,"end":278},"obj":"Chemical"}],"attributes":[{"id":"A84","pred":"chebi_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/CHEBI_73925"},{"id":"A85","pred":"chebi_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/CHEBI_73812"},{"id":"A86","pred":"chebi_id","subj":"T86","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"},{"id":"A87","pred":"chebi_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/CHEBI_138655"},{"id":"A88","pred":"chebi_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/CHEBI_76181"}],"text":"A major region of this tSNE map present in COVID-19 patients, but not HD or RD, were CD8 T cells that enriched for expression of CD38, HLA-DR, KI67, CD39, and PD1 (Fig. 2G), highlighting the co-expression of these activation markers with other features including CD95 (i.e., FAS)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T109","span":{"begin":0,"end":280},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A major region of this tSNE map present in COVID-19 patients, but not HD or RD, were CD8 T cells that enriched for expression of CD38, HLA-DR, KI67, CD39, and PD1 (Fig. 2G), highlighting the co-expression of these activation markers with other features including CD95 (i.e., FAS)."}